CF PharmTech, Inc. Raises USD $65 Million to Accelerate the Development of Company#s Inhalation Products and Manufacturing Capacity to Global Market

Food and Healthcare Press Releases Monday August 28, 2017 10:44
SUZHOU, China--28 Aug--PRNewswire/InfoQuest

CF PharmTech, Inc. ("CF PharmTech"), a leading specialty pharmaceutical company that develops and manufactures inhalation products, announced today that it has raised $65M in a Series D financing. Future Industry Investment Fund, a private equity fund managed by SDIC Fund Management Corporation Limited ("SDIC Fund Management"), led the financing along with other prestigious healthcare investment groups in China.

CF PharmTech, founded by seasoned industry experts and entrepreneurs with a successful track record in the US pharmaceutical industry, is focused on the development, manufacturing and commercialization of high-quality inhalation products for the global market. Since its inception, CF PharmTech has established state-of-art research and manufacturing facilities to advance its product development. This new round of investment will not only expedite the submission of its product pipeline to meet regulatory approvals in China and abroad, but also expand its CDMO service to international clients.

Mr. Hai Lu, Managing Director of SDIC Fund Management, commented: "Drug delivery via pulmonary route bears significant technical challenges and it takes extraordinary effort to bring inhalation products to the market. CF PharmTech's high caliber team has proved their ability to attract top industry talents to develop inhalation products for the global market. We are confident that they will achieve their business mission in the near future."

CF PharmTech, headquartered in Suzhou, China, develops metered dose inhaler, inhalation powder, nasal spray and blow-fill-seal products. It has established high-quality research and manufacturing environments to be compliant with US, EU and Chinese regulations. CF PharmTech aims to provide quality and cost-effective inhalation products for domestic market, and seeks strategic partnerships to co-develop and commercialize its products globally.

About SDIC Fund Management Corporation Limited

Established in July 2009, SDIC Fund Management Corporation Limited is an independent, professional private equity firm. It currently manages and advises more than RMB 50 billion of capital for a wide range of institutional investors including financial institutions, pension funds, and state-owned and private capital. SDIC Fund Management Corporation Limited is one of the largest, professional private equity fund managers in China. The core strategy of SDIC Fund Management is to invest in market leading companies with attractive growth prospects and outstanding management teams.


Latest Press Release

Mindray Debuts High-end Ventilator SV800 in Vienna

Mindray announced that its new-generation ventilator SV800 has been officially released. The new ventilator was showcased for the first time at the ESICM 2017 held in Vienna. The SV800, as a high-end ventilator featured with a 1080P HD wide screen,...

European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

- First approved immunotherapy for rare and aggressive skin cancer in the European Union, with initial launches planned in Germany and the UK - Builds on Bavencio's previous accelerated approvals in the US and recent approval in Switzerland - Approval is...

Terumo BCT Expands Collaboration With Mallinckrodt to Bring More Treatment Options to Patients

Expanded collaboration will bring a specialized treatment option to more patients who can be helped with extracorporeal photopheresis (ECP) to treat certain immune-mediated diseases Terumo BCT, a global leader in blood component, therapeutic apheresis...

Identifying extreme impact in research, Clarivate Analytics uses citations to forecast Nobel Prize winners

Clarivate Analytics, the global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced its 2017 Citation Laureates. Each year since 2002, analysts at Clarivate Analytics have mined millions of citations...

Institut Marques presents their studies on music and the beginning of life at the Massachusetts Institute of Technology

- Dr. Marisa Lopez-Teijon, director of this internationally renowned center in Assisted Reproduction, has received the Ig Nobel Prize for Medicine - The awards, held at Harvard University, recognize the most surprising and innovative scientific...

Related Topics